ATS 2022: Approach to Lung Nodules in 2022

Shaheen Islam

Post COVID-19 Lung Complications

3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

M. Padilla

ATS 2025 Insights: Association of Pulse Dose Corticosteroids With Ou…

Insights from 2025 ATS Annual Meeting

D. Shankar

Approaching Sarcoidosis Therapy From a 21st Century Perspective

CHEST 2022 Coverage

D. Culver

A Radiologist's Approach to Subsolid Pulmonary Nodules

CHEST 2022 Coverage

A. Guttentag

Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

Panel Discussion Chaired by Dr. Weichart on Big Data and How to Move…

WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

T. Weichhart

Advances and Updates in Sarcoidosis: Diagnosis and Treatment of Pulm…

UCLA Health

J. Belperio

Sarcoidosis: Diagnosis and Management

University of Colorado Department of Medicine

N. Held

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

CHEST 2022 Coverage

T. Kulkarni

Bronchoscopic Imaging for Interstitial Lung Disease

CHEST 2022 Coverage

G. Zhi Cheng

Progressive Pulmonary Fibrosis (PPF): Part 2

Pulmonology Read Aloud

A. Aneja Arora

Rituximab versus Cyclophosphamide for the Treatment of Connective Ti…

Toby Maher

Management of Pulmonary Fibrosis in Clinical Practice

National Jewish Health

J. Solomon

ATS 2025 Insights: Applying the Guidelines: IPF, PPF, and CPFE

Insights from 2025 ATS Annual Meeting

C. Lee

Interstitial Lung Disease: Multidisciplinary Discussion

UCLA Health

S. Sam Weigt, E. R. Volkmann, F. Abtin, M. Fishbein

Current and Evolving Paradigm of Anti-Inflammatory Therapy in Pulmon…

Temple Lung Center

R. Gupta

Interstitial Lung Disease in RA: RA-ILD Subtypes, Mortality Risk, RA…

RheumNow

J. Sparks, J. Cush